News for hackers. Stuff that matters.

stadt

Re:The Cost of Grid Inertia on Thursday May 01, 2025 @04:38AM (#43855067)
Also see this article subtitled "Inertia and why we need it": https://www.worksinprogress.news/p/the-spanish-grid-collapse
Re:The Cost of Grid Inertia on Thursday May 01, 2025 @04:36AM (#43855049)
Interesting analysis. Anyone able to confirm or refute it?
Re:100k Stars on Sunday May 12, 2024 @01:15PM (#40335975)
Still crazy after all these years... https://news.ycombinator.com/item?id=4784821

Perhaps update the title with (2012)?

Re:Visiting the annual Braun collectors fair on Monday May 06, 2024 @03:37PM (#40278660)
If you love "everyday objects from the 20th century, especially electrical appliances" and are in Valencia, Spain, then checkout the Alfaro Hofmann Collection which has some lovely Braun pieces shown in the context of many other designs: https://www.alfarohofmann.com/en/holdings/s?filtered=1&fabri...
Re:Tallow in Plastic Bank Notes on Monday January 02, 2023 @05:11PM (#34224384)
Please add year [2016]
Still waiting for the pictographic subtitles to load... ;D
Re:Teaching our five year old to code by cheating on Wednesday October 07, 2020 @06:04AM (#24706742)
That's the real teachable moment ;P line 9: guess = int(input(question))
Re:Teaching our five year old to code by cheating on Wednesday October 07, 2020 @06:01AM (#24706729)
As the random lulu and boonie are already integers you only need to edit line 9: guess = int(input(question))
Re:Autodesk criticised by architects on Monday August 03, 2020 @05:32AM (#24035690)
An interesting counterpoint comes from Autodesk Life Sciences which outlines the need for Bio/Nano software development: https://doi.org/10.1007/s10295-018-2009-5

Abstract: "There is a digital revolution taking place and biotechnology companies are slow to adapt. Many pharmaceutical, biotechnology, and industrial bio-production companies believe that software must be developed and maintained in-house and that data are more secure on internal servers than on the cloud. In fact, most companies in this space continue to employ large IT and software teams and acquire computational infrastructure in the form of in-house servers. This is due to a fear of the cloud not sufficiently protecting in-house resources and the belief that their software is valuable IP. Over the next decade, the ability to quickly adapt to changing market conditions, with agile software teams, will quickly become a compelling competitive advantage. Biotechnology companies that do not adopt the new regime may lose on key business metrics such as return on invested capital, revenue, profitability, and eventually market share."